Hodges Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,850
Closed -$263K 213
2025
Q4
$263K Buy
+2,850
New +$273K 0.02% 179
2025
Q3
Sell
-3,000
Closed -$389K 213
2025
Q2
$389K Hold
3,000
0.04% 168
2025
Q1
$478K Hold
3,000
0.05% 176
2024
Q4
$556K Hold
3,000
0.03% 173
2024
Q3
$633K Buy
+3,000
New +$521K 0.04% 171
2020
Q4
Sell
-1,600
Closed -$206K 210
2020
Q3
$206K Sell
1,600
-1,400
-47% -$154K 0.04% 188
2020
Q2
$261K Buy
+3,000
New +$231K 0.05% 164
2018
Q4
Sell
-76,300
Closed -$3.21M 244
2018
Q3
$3.21M Sell
76,300
-40,800
-35% -$1.92M 0.24% 91
2018
Q2
$4.18M Buy
+117,100
New +$3.78M 0.31% 82

Other funds holding INSP

Hodges Capital Management's INSP Position: Q1 2026 in Review

Hodges Capital Management sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 2,850 shares — an estimated $263K sold.

Hodges Capital Management first reported a position in INSP in Q2 2018 and held it in 9 quarters. The position peaked at $4.18M in Q2 2018. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Hodges Capital Management reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Hodges Capital Management sold 2,850 Inspire Medical Systems shares in Q1 2026, an estimated $263K.
  • Hodges Capital Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 9 quarters.
  • Hodges Capital Management's Inspire Medical Systems position peaked at $4.18M in Q2 2018.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Hodges Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.